ArticleBMJ open2021

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.

Anna-Maria Hoffmann-Vold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.